Document is current
Any future updates will be listed below
-
Authors
Swart, Maarten https://orcid.org/0000-0001-6109-0773
van der Lubbe, Joan
Schmit-Tillemans, Sonja
van Huizen, Ella
Verspuij, Johan
Gil, Ana Izquierdo https://orcid.org/0000-0001-9557-1807
Choi, Ying
Daal, Chenandly
Perkasa, Aditya
de Wilde, Adriaan
Claassen, Erwin
de Jong, Rineke https://orcid.org/0000-0002-2052-5993
Wiese, Katrin E.
Cornelissen, Lisette
van Es, Marieke
van Heerden, Marjolein
Kourkouta, Eleni
Tahiri, Issam
Mulders, Michel
Vreugdenhil, Jessica
Feddes - de Boer, Karin
Muchene, Leacky
Tolboom, Jeroen
Dekking, Liesbeth
Juraszek, Jarek
Vellinga, Jort
Custers, Jerome
Bos, Rinke
Schuitemaker, Hanneke https://orcid.org/0000-0001-8563-2266
Wegmann, Frank https://orcid.org/0000-0002-9821-1492
Roozendaal, Ramon https://orcid.org/0000-0002-4084-4801
Kuipers, Harmjan https://orcid.org/0000-0003-1317-394X
Zahn, Roland https://orcid.org/0000-0003-2822-6231
- License Information
-
More Information
Article History
Received: 27 December 2022
Accepted: 20 February 2023
First Online: 16 March 2023
Competing interests
: The authors indicated with affiliation references <sup>1,3</sup> and <sup>4</sup> were employees of Janssen Pharmaceutical Companies of Johnson & Johnson at the time of the study and may have ownership of shares in Janssen Pharmaceutical Companies of Johnson & Johnson. R.Z., F.W., and H.S are co-inventors on provisional vaccine patents (62/969,008; 62/994,630).
